Upper Urinary Tract Trauma: Difference between revisions

Line 197: Line 197:
=== <span style="color:#ff0000">Pathogenesis ===
=== <span style="color:#ff0000">Pathogenesis ===


* Acute ureteral injury results from (3):  
* '''Acute ureteral injury results from (3):'''
** Iatrogenic injury (open surgery, laparoscopy, and endoscopic procedures)
*# '''Iatrogenic injury''' (open surgery, laparoscopy, and endoscopic procedures)
** External violence from high-speed blunt mechanisms
*# '''External violence''' from high-speed blunt mechanisms
** The presence of massive force injuries in the patient with blunt trauma should always increase the level of suspicion for ureteral injury
*##The presence of massive force injuries in the patient with blunt trauma should always increase the level of suspicion for ureteral injury
** Penetrating stab and gunshot wounds
*# '''Penetrating stab and gunshot wounds'''


* Iatrogenic injury  
* '''Iatrogenic injury'''
** Procedures most commonly associated with iatrogenic ureteral injuries:  
** '''Procedures most commonly associated with iatrogenic ureteral injuries:'''
*** Hysterectomy (54%)
*** '''Hysterectomy (54%)'''
*** Colorectal surgery (14%)
*** Colorectal surgery (14%)
*** Ovarian tumor removal (8%)
*** Ovarian tumor removal (8%)
Line 212: Line 212:
** Compared to open surgery, ureteral injuries during laparoscopic surgery are less likely to be recognized immediately.  
** Compared to open surgery, ureteral injuries during laparoscopic surgery are less likely to be recognized immediately.  
*** During laparoscopy/robotic surgery, a high index of suspicion for ureteral injury is required.
*** During laparoscopy/robotic surgery, a high index of suspicion for ureteral injury is required.
*** In open surgery, 1/3 of ureteral injuries are recognized immediately.  
*** In open surgery, 1/3 of ureteral injuries are recognized immediately.
*** Intraoperative assessment of ureters   
*** Intraoperative assessment of ureters   
**** Some have advocated maneuvers to check the patency of the ureter after all surgeries in which ureteric injury is commonly reported (e.g., hysterectomy).  
**** Some have advocated maneuvers to check the patency of the ureter after all surgeries in which ureteric injury is commonly reported (e.g., hysterectomy).
**** Options (3):   
**** Options (3):   
***** Direct inspection  
***** Direct inspection  
****** Purposefully opening the retroperitoneum before or after hysterectomy has been advocated to avoid ureteral injury or at least allow intraoperative detection.  
****** Purposefully opening the retroperitoneum before or after hysterectomy has been advocated to avoid ureteral injury or at least allow intraoperative detection.
***** Injection of 5-10 mL of IV methylene blue or indigo carmine dye followed by cystoscopy   
***** Injection of 5-10 mL of IV methylene blue or indigo carmine dye followed by cystoscopy   
****** Poor predictor of injury  
****** Poor predictor of injury
****** Goal of cystoscopy is to document the absence of hematuria and the presence of bilateral ureteral jets  
****** Goal of cystoscopy is to document the absence of hematuria and the presence of bilateral ureteral jets
****** IV methylene blue and indigo carmine are generally considered to be benign drugs, but their use has resulted in patient deaths and fetal deaths when used in pregnant women.   
****** IV methylene blue and indigo carmine are generally considered to be benign drugs, but their use has resulted in patient deaths and fetal deaths when used in pregnant women.   
******* Contraindications for IV methylene blue (3):  
******* Contraindications for IV methylene blue (3):  
******** Pregnancy  
******** Pregnancy
******** Use of selective (e.g., paroxetine, sertraline, fluoxetine, fluvoxamine, citalopram) or nonselective (e.g., imipramine) serotonin reuptake inhibitors  
******** Use of selective (e.g., paroxetine, sertraline, fluoxetine, fluvoxamine, citalopram) or nonselective (e.g., imipramine) serotonin reuptake inhibitors  
********* Methylene blue is a potent monoamine oxidase inhibitor and has caused deaths from serotonin toxicity in patients taking medications that increase serotonin levels  
********* Methylene blue is a potent monoamine oxidase inhibitor and has caused deaths from serotonin toxicity in patients taking medications that increase serotonin levels
******** Glucose-6-phosphate dehydrogenase deficiency   
******** Glucose-6-phosphate dehydrogenase deficiency   
********* Causes methemoglobinemia and hemolysis  
********* Causes methemoglobinemia and hemolysis
******* Contraindications for IV indigo carmine:   
******* Contraindications for IV indigo carmine:   
******** Pregnancy  
******** Pregnancy
******** IV indigo carmine has been implicated in rare but serious cases of bronchospasm, bradycardia, hypertension, hypotension (most common), and anaphylactoid reactions.  
******** IV indigo carmine has been implicated in rare but serious cases of bronchospasm, bradycardia, hypertension, hypotension (most common), and anaphylactoid reactions.
**** Retrograde pyelography  
**** Retrograde pyelography
**** Not effective   
**** Not effective   
***** Intraooperative single-shot IVP  
***** Intraooperative single-shot IVP
***** Intraoperative hydration or diuretic administration   
***** Intraoperative hydration or diuretic administration   
****** Has been suggested to enhance ureteral visualization and potentially decrease the risk for injury  
****** Has been suggested to enhance ureteral visualization and potentially decrease the risk for injury
****** No data to support this method  
****** No data to support this method
***** Digital palpation of the ureter  
***** Digital palpation of the ureter  
****** Appears to be ineffective  
****** Appears to be ineffective
***** Grasping the ureter with forceps to evoke ureteral peristalsis   
***** Grasping the ureter with forceps to evoke ureteral peristalsis   
****** Highly ineffective; should never be relied upon.  
****** Highly ineffective; should never be relied upon.


* Preoperative ureteral stenting  
* Preoperative ureteral stenting